J&J, Macleods in talks for license deal of TB drug

Mumbai-based Macleods Pharmaceuticals and US drug giant Johnson & Johnson (J&J) are in talks for a voluntary license deal for the TB drug bedaquiline.

To read the full article, click here.


Source: The Economic Times

To subscribe to the Weekly Newsletter of new posts, enter your email here:


News

By Divya Rajagopal

Published: March 15, 2018, 7:47 p.m.

Last updated: March 15, 2018, 8:51 p.m.

Print Share